HCAT vs LOB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 20, 2026

HCAT

48.3
AI Score
VS
LOB Wins

LOB

59.0
AI Score

Investment Advisor Scores

HCAT

48score
Recommendation
HOLD

LOB

59score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric HCAT LOB Winner
Forward P/E 10 10.1937 HCAT
PEG Ratio 0 0 Tie
Revenue Growth -12.7% 12.2% LOB
Earnings Growth 0.0% 45.1% LOB
Tradestie Score 48.3/100 59.0/100 LOB
Profit Margin -90.6% 26.5% LOB
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY LOB

Relative Price Performance (Last 90 Days)

HCAT 1M: -7.9% · 3M: -13.4% LOB 1M: -6.7% · 3M: -17.1%

Current Technical Phase

HCAT

Distribution
Trim / tighten stop

Price near a flattening SMA50 (slope -7.8%) with fading momentum, RSI 48

RSI (14): 48.2 · Price: $1.74

LOB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -6.8%), weak momentum, RSI 41

RSI (14): 41.3 · Price: $35.35

Fundamentals Snapshot

Metric HCAT LOB
Market Cap — —
Forward P/E 232.0 8.3
Trailing P/E — 12.4
Revenue (TTM) — —
Revenue Growth -0.1% 0.1%
Gross Margin 0.5% 1.0%
Operating Margin -0.1% 0.4%
EPS -3.69 2.85
Dividend Yield — 0.00%

Frequently Asked Questions

Based on our detailed analysis, LOB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.